Lung Factor

30/09/2023

https://respiratory-research.biomedcentral.com/articles/10.1186/s12931-023-02540-0

Background Idiopathic pulmonary fibrosis (IPF) has an unknown aetiology and limited treatment options. A recent meta-analysis identified three novel causal variants in the TERT, SPDL1, and KIF15 genes. This observational study aimed to investigate whether the aforementioned variants cause clinical p...

01/04/2022

“ study suggests that fiber burden, but not fiber type, may have an impact on the prognosis of malignant pleural . Learn More: https://t.co/9mMRorPgxC ”

15/02/2022

Although asbestos exposure is the most common cause of malignant mesothelioma (MM), an aggressive cancer of the pleura or peritoneum, up to 7% of pati…

23/12/2021

Merry Christmas and Happy New Year!

18/12/2020

Merry Christamas and Research-rich year 2021 to All of You !

Joulumuistamisten asemasta teimme lahjoitukset Hope ry:lle ja Hurstinapu ry:lle.

01/12/2020

Kati Mäkelän artikkeli tekoälyn hyödyntämisestä IPF potilaiden kudosnäytteiden kanssa.

A large number of fibroblast foci (FF) predict mortality in idiopathic pulmonary fibrosis (IPF). Other prognostic histological markers have not been i…

06/10/2020

Onnittelut Severille ekasta osajulkaisusta. Olemme tunnistaneet idiopaattista keuhkofibroosia sairastavilta potilailta kolme oireklusteria, joita voidaan käyttää potilaiden oireenmukaisen hoidon kehittämisessä!

Idiopathic pulmonary fibrosis (IPF) is a severe and progressive lung disease with a poor prognosis. Patients with IPF suffer from a high symptom burden, which impairs their health-related quality of life (HRQoL). Lack of research on IPF symptoms and their clustering, however, makes symptom-centred c...

06/10/2020

Check out our latest publications!

Idiopathic pulmonary fibrosis (IPF) is a severe and progressive lung disease with a poor prognosis. Patients with IPF suffer from a high symptom burden, which impairs their health-related quality of life (HRQoL). Lack of research on IPF symptoms and their clustering, however, makes symptom-centred c...

26/08/2020

LL Juuso Paajanen väittelee 28.8.2020 kello 15 Helsingin yliopiston lääketieteellisessä tiedekunnassa aiheesta "PROGNOSTIC FACTORS IN MALIGNANT PLEURAL MESOTHELIOMA".

LIVESTREAM:

https://tinyurl.com/yxvlp97j

14/08/2020

https://www.helsinki.fi/en/researchgroups/lung-factor/blogs

Käy lukemassa mitä kuului lääkisopiskelijoiden kesään Lung factor tutkimusryhmässä.

Lung factorin blogit

10/06/2020

(2020). Tele-rounding in a university hospital pulmonary ward during the COVID-19 pandemic: a pilot study. Infectious Diseases. Ahead of Print.

13/05/2020

https://twitter.com/EUkomissio/status/1259874106717044737?s=20

“Jere Reijula työskentelee keuhkosairauksien osastolla, jolla ensimmäisiä koronaviruspotilaita alettiin hoitaa Suomessa. ”On äärimmäisen tärkeää, että näinä vaikeina aikoina me työskentelemme yhdessä." https://t.co/nGlzSGfNzD https:/...